文献速递关节外科创伤骨科

全髋关节置换术后假体周围感染的长期结局:瑞典10年随访

What Are the Long-term Outcomes of Mortality, Quality of Life, and Hip Function after Prosthetic Joint Infection of the Hip? A 10-year Follow-up from Sweden.
PubMed 文献 · Clin Orthop Relat Res · 2021-01-01

本研究基于瑞典国家数据库,纳入442例初次全髋置换后假体周围感染(PJI)患者,并与无感染患者比较。中位随访至少10年发现,PJI患者10年全因死亡率更高(45% vs 29%),生活质量、髋关节功能更差,且多次翻修和手术入路与更差功能相关。

要点

  • 全髋置换后PJI患者10年死亡率显著高于无感染患者(45% vs 29%)。
  • PJI患者长期生活质量、居住状态和髋关节功能均显著差于匹配对照。
  • 三次或以上翻修及直接外侧入路与更差髋关节功能相关。

核心结论

  • 全髋关节置换术后假体周围感染对死亡率、长期健康相关生活质量和髋关节功能均有负面影响。
  • 可干预因素如翻修次数和手术入路与更差的髋关节功能相关,强调早期恰当治疗以减少重复手术的重要性。

研究设计与样本

  • 基于瑞典髋关节置换登记库(SHAR)的全国性研究,纳入2005至2008年瑞典所有初次全髋置换患者(n=45,570),其中442例发生PJI。
  • 死亡率与剩余45,128例无PJI患者比较;PROM分析为每例存活PJI患者匹配3例对照(按年龄、性别、手术指征和手术年份)。
  • 2008年亚组分析调整合并症(ASA评分);问卷随访平均11年。

主要发现

  • 调整性别、年龄和手术指征后,PJI患者10年全因死亡率为45%,无PJI患者为29%(OR 1.4 [95% CI 1.2 to 1.6];p < 0.001)。
  • PJI患者EQ-5D-5L指数评分更低(0.83 vs 0.94,差值-0.13 [95% CI -0.18 to -0.08];p < 0.001)。
  • PJI患者需要辅助居住的比例更高(21% vs 12%,OR 2.0 [95% CI 1.2 to 3.3];p = 0.01),需要行走辅助工具的比例更高(65% vs 42%,OR 3.1 [95% CI 2.1 to 4.8];p < 0.001)。
  • PJI患者牛津髋关节评分(OHS)更低(36 vs 44,差值-5.9 [95% CI -7.7 to -4.0];p < 0.001)。
  • PJI患者中,三次或以上翻修与更低OHS相关(-8.0 [95% CI -13.0 to -3.2];p = 0.01),翻修时直接外侧入路较后侧入路与更低OHS相关(-4.3 [95% CI -7.7 to -0.9];p = 0.01)。

关键数值与推荐

  • PJI患者10年全因死亡率45%,无PJI患者29%(OR 1.4 [95% CI 1.2 to 1.6];p < 0.001)。
  • EQ-5D-5L指数评分PJI组0.83,对照组0.94(差值-0.13 [95% CI -0.18 to -0.08];p < 0.001)。
  • 辅助居住比例PJI组21%,对照组12%(OR 2.0 [95% CI 1.2 to 3.3];p = 0.01)。
  • 需要行走辅助工具比例PJI组65%,对照组42%(OR 3.1 [95% CI 2.1 to 4.8];p < 0.001)。
  • OHS评分PJI组36,对照组44(差值-5.9 [95% CI -7.7 to -4.0];p < 0.001)。

临床怎么用

  • 临床应重视全髋置换术后PJI的长期不良影响,包括死亡风险增加和功能下降。
  • 通过早期恰当治疗减少重复翻修手术,可能有助于减轻PJI的长期负面后果。
  • 翻修手术中选择后侧入路而非直接外侧入路可能与更好的髋关节功能相关。

局限性

  • 本研究为观察性设计,证据等级为III级。
  • PJI组与对照组在合并症等方面可能存在差异,仅2008年亚组可调整ASA评分。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prosthetic joint infection (PJI) is a complication after arthroplasty that negatively affects patient health. However, prior reports have not addressed the long-term consequences of hip PJI in terms of patient mortality, quality of life, and hip function. QUESTIONS/PURPOSES: At a minimum of 10 years after PJI in patients undergoing primary THA, in the context of several large, national databases in Sweden, we asked: (1) Is mortality increased for patients with PJI after THA compared with patients with a noninfected THA? (2) Does PJI of the hip have a negative influence on quality of life as measured by the Euro-QoL-5D-5L (EQ-5D-5L), ambulatory aids, residential status, and hip function as measured by the Oxford Hip Score (OHS)? (3) Which factors are associated with poor patient-reported outcome measures (PROMs) for patients with PJI after primary THA? METHODS: This study included 442 patients with a PJI after primary THA, from a previously published national study, including all patients with a THA performed from 2005 to 2008 in Sweden (n = 45,570) recruited from the Swedish Hip Arthroplasty Registry (SHAR). Possible deep PJIs were identified in the Swedish Dispensed Drug Registry and verified by review of medical records. Mortality in patients with PJI was compared with the remaining cohort of 45,128 patients undergoing primary THA who did not have PJI. Mortality data were retrieved from the SHAR, which in turn is updated daily from the population registry. A subgroup analysis of patients who underwent primary THA in 2008 was performed to adjust for the effect of comorbidities on mortality, as American Society of Anesthesiologists (ASA) scores became available in the SHAR at that time. For the PROM analysis, we identified three controls matched by age, gender, indication for surgery, and year of operation to each living PJI patient. A questionnaire including EQ-5D-5L, ambulatory aids, residential status, and OHS was collected from patients with PJI and controls at a mean of 11 years from the primary procedure. Apart from age and gender, we analyzed reoperation data (such as number of reoperations and surgical approach) and final prosthesis in situ to explore possible factors associated with poor PROM results. RESULTS: After controlling for differences in sex, age, and indication for surgery, we found the all-cause 10-year mortality higher for patients with PJI (45%) compared with patients undergoing THA without PJI (29%) (odds ratio 1.4 [95% CI 1.2 to 1.6]; p < 0.001). The questionnaire, with a minimum of 10 years of follow-up, revealed a lower EQ-5D-5L index score (0.83 versus 0.94, -0.13 [95% CI -0.18 to -0.08; p < 0.001]), greater proportion of assisted living (21% versus 12%, OR 2.0 [95% CI 1.2 to 3.3]; p = 0.01), greater need of ambulatory aids (65% versus 42%, OR 3.1 [95% 2.1 to 4.8]; p < 0.001), and a lower OHS score (36 versus 44, -5.9 [-7.7 to -4.0]; p < 0.001) for patients with PJI than for matched controls. Factors associated with lower OHS score for patients with PJI were three or more reoperations (-8.0 [95% CI -13.0 to -3.2]; p = 0.01) and a direct lateral approach used at revision surgery compared with a posterior approach (-4.3 [95% CI -7.7 to -0.9]; p = 0.01). CONCLUSION: In this study, we found that PJI after THA has a negative impact on mortality, long-term health-related quality of life, and hip function. Furthermore, the subgroup analysis showed that modifiable factors such as the number of reoperations and surgical approach are associated with poorer hip function. This emphasizes the importance of prompt, proper initial treatment to reduce repeated surgery to minimize the negative long-term effects of hip PJI. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Wildeman P, Rolfson O, Söderquist B, et al. What Are the Long-term Outcomes of Mortality, Quality of Life, and Hip Function after Prosthetic Joint Infection of the Hip? A 10-year Follow-up from Sweden. Clin Orthop Relat Res. 2021. PMID: 34061486. doi:10.1097/CORR.0000000000001838

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。